5-MeO-DMT bufo
Selected indexed studies
- Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. (Front Psychol, 2018) [PMID:30574112]
- Bufo alvarius: a potent hallucinogen of animal origin. (J Ethnopharmacol, 1994) [PMID:8170151]
- Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. (Front Psychiatry, 2021) [PMID:34220590]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. (2018) pubmed
- Bufo alvarius: a potent hallucinogen of animal origin. (1994) pubmed
- Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. (2021) pubmed
- Elevated Endogenous Psychedelic Bufotenine in the Urine of Patients Diagnosed With a Mental Illness: A Systematic Review. (2025) pubmed
- The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. (2018) pubmed
- A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. (2019) pubmed